Oregon Public Employees Retirement Fund lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 256,709 shares of the healthcare conglomerate’s stock after selling 2,800 shares during the period. UnitedHealth Group makes up approximately 0.8% of Oregon Public Employees Retirement Fund’s portfolio, making the stock its 13th largest position. Oregon Public Employees Retirement Fund’s holdings in UnitedHealth Group were worth $47,599,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Patriot Financial Group Insurance Agency LLC raised its stake in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC raised its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management raised its position in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Intellectus Partners LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $111,000. Finally, Thomas J. Herzfeld Advisors Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $111,000. 86.37% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Incorporated (UNH) traded up 0.23% on Friday, hitting $193.02. 2,210,720 shares of the stock traded hands. The company’s 50 day moving average price is $189.18 and its 200-day moving average price is $174.51. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The stock has a market cap of $186.62 billion, a price-to-earnings ratio of 23.19 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.96 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
WARNING: This story was published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.com-unik.info/2017/08/11/unitedhealth-group-incorporated-unh-position-lowered-by-oregon-public-employees-retirement-fund-updated-updated-updated.html.
A number of equities analysts have commented on UNH shares. Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price on the stock in a report on Monday, May 15th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a report on Tuesday, May 30th. BidaskClub raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Morgan Stanley raised their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. Finally, Mizuho raised their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $202.20.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock worth $2,873,320 over the last three months. 0.89% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.